Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed this Form 8-K on February 1, 2017, to report its financial results for the fourth quarter and full year ended December 31, 2016. The primary purpose of this filing is to provide investors with timely access to the company's performance as detailed in an accompanying press release, which is furnished as Exhibit 99.1. While the 8-K itself does not contain detailed financial figures, it serves as a crucial gateway to the company's official earnings announcement. Investors and analysts should refer to the press release (Exhibit 99.1) for specific metrics such as revenue, earnings per share, membership growth, and any forward-looking guidance or strategic commentary provided by management for the period.
Key Highlights
- 1The 8-K filing by Anthem, Inc. (now Elevance Health) on February 1, 2017, announces their financial results for the fourth quarter and full year of 2016.
- 2The report incorporates by reference a press release dated February 1, 2017, which contains the detailed financial performance information.
- 3This filing is primarily informational, directing investors to the press release for specific financial data and operational highlights.
- 4Key financial metrics for Q4 and FY 2016, such as revenue, net income, and earnings per share, are available in the referenced press release (Exhibit 99.1).
- 5The filing does not include new financial statements but rather a notification of the release of results.
- 6Investors should consult Exhibit 99.1 for details on membership, operating costs, and any outlook provided by the company.
- 7The information furnished in this 8-K is not deemed 'filed' for Section 18 purposes, meaning it does not carry the same legal implications as a formally filed financial statement.